Filing Flows

Filing Flows › 8-K events › Picard Medical

Picard Medical: entry into a material definitive agreement

Form 8-K filed Oct 23, 2026 · items 1.01, 3.02

What the filing says

On October 20, 2026, Picard Medical, Inc. (the “Company”) entered into a Warrant Amendment and Exchange Agreement (the “Exchange Agreement”) with the placement agent (the “Warrant Holder”) of its private placement closed on December 26, 2025 (the “December 2025 Private Placement”), and such Warrant Holder’s employee de

Read the filing on SEC EDGAR →

What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 3.02: +0.1% next session across 2,750. Every item ranked →

What this kind of filing means

Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.

Picard Medical at a glance

Latest quarterQ2 2026
Revenue$3.0M
Revenue Y/Y+39%
Operating margin-156.7%
IndustrySurgical & Medical Instruments & Apparatus

Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%. The chart follows the revenue to costs, profit and cash.

Picard Medical: every quarter, Q/Q and Y/Y, holders and guidance →

Picard Medical’s other material 8-Ks

Other recent share offerings

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.